Product Detail
Geranylgeraniol-13C4
Geranylgeraniol Stable Isotopes
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotopes
API Family
Geranylgeraniol
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
Geranylgeraniol-13C4 Product Information
Geranylgeraniol-13C4 is listed under Stable Isotopes. It is associated with Geranylgeraniol and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-103952.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
Geranylgeraniol-13C4
CAS No.
187268-51-5
CAT No.
CS-T-103952
Molecular Formula
C₁₆¹³C₄H₃₄O
Molecular Weight
294.45
Category
API Family
Storage Condition
Refer MSDS for complete information.
SMILES
C/C(C)=C\CC/C(C)=C/CC/C(C)=C/C[13CH2]/[13C](C)=[13CH]/[13CH2]O
IUPAC Name
(2E,6E,10E)-3,7,11,15-Tetramethyl-2,6,10,14-hexadecatetraen-1-ol-13C4; (E,E,E)- 3,7,11,15-Tetramethyl-2,6,10,14-hexadecatetraen-1-ol-13C4; (E,E,E)-Geranylgeraniol-13C4; All-trans-Geranylgeraniol-13C4; trans,trans,trans-Geranylgeraniol-13C4;-13C4 trans-Geranylgeraniol-13C4
Hazard Compound
Refer MSDS for complete information.
Description
Overview
Geranylgeraniol-13C4, is the labeled analogue of Geranylgeraniol (G367501), an intermediate in the mevalonate pathway. Geranylgeraniol has been shown to prevent bone re-adsorption, inhibition of osteoclast formation, and kinase activation in vitro.
Synonyms
(2E,6E,10E)-3,7,11,15-Tetramethyl-2,6,10,14-hexadecatetraen-1-ol-13C4
Application Notes
Geranylgeraniol-13C4, is the labeled analogue of Geranylgeraniol (G367501), an intermediate in the mevalonate pathway. Geranylgeraniol has been shown to prevent bone re-adsorption, inhibition of osteoclast formation, and kinase activation in vitro.
References
Aiuchi, T., et al.: J. Biochem., 124, 300 (1998); Fisher, J.E., et al.: Proc. Natl. Acad. Sci. U.S.A. 96, 133 (1999); Montero, M.T., et al.: J. Immunol., 173, 4936 (2004); Campia, I., et al.: Br. J. Pharmacol., 158, 1777 (2009)